Drug Trial Radar · NCT02099123
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
Last checked: Nov 19, 2026Latest source record: Nov 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
9,971
Actual
Start
Jul 2015
Primary completion
Dec 2025
Study completion Dec 2025
Sponsor
- Lead sponsor
- Monash UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Health and Medical Research Council, Australia; National Heart Foundation, Australia
- First posted
- Mar 28, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The STAREE study will examine whether treatment with statin (atorvastatin 40mg) compared with placebo will prolong disability free survival and reduce major cardiovascular events amongst healthy elderly people (≥70 years).
Conditions
- Independent Living
- Disability Free Survival
- Elderly
- Healthy
Interventions
AtorvastatinDrug
Atorvastatin 20 mg tablet
Placebo (for Atorvastatin)Drug
Inactive pill manufactured to mimic Atorvastatin 20 mg tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disability free survival - death or development of dementia or development of persistent physical disabilityTime frame: Time from randomisation to a primary endpoint or censoring at the end of study follow-up which is anticipated to be an average 6 years.
- Major cardiovascular eventsTime frame: Time from randomisation to a primary endpoint or censoring at the end of study follow-up which is anticipated to be an average 6 years.
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Queensland
Brisbane, Australia
New South Wales
Newcastle, Australia
Western Australia
Perth, Australia
Tasmania
Hobart, Tasmania, Australia
Victoria
Melbourne, Victoria, Australia
South Australia
Adelaide, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.